Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

COVID-19: Will the disease or the cure cause more death?

Craig Goolsby, MD, MEd, Raphaelle H. Rodzik, MPH, Nicole Dacuyan-Faucher, MPH, Keke Schuler, PhD, Thomas Kirsch, MD, MPH
Conditions
April 5, 2020
Share
Tweet
Share

There have been increasing statements in the media to the effect that, for the COVID-19 pandemic, “the cure is worse than the disease,” and that the economic impact of the drastic and widespread quarantines will cause a severe recession that will result in excess deaths. This is very unlikely, as the overall U.S. mortality from unchecked COVID-19 would likely exceed the mortality from an economic recession resulting from the public health measures used to contain its spread.

The currently available medical interventions are limited. There are no known vaccines or proven medication regimens for COVID-19. Travel restrictions initially slowed the spread of the infection to the U.S. But, the limited number of tests prevents widespread case identification, and the very limited public health workforce at the local level makes contact tracing with multiple infections virtually impossible. The remaining strategies which focus on reducing population spread have been employed globally with varying success. These include an array of options ranging from individual case isolation to nationwide “lockdowns.”

The worst-case projections are truly frightening. The U.K.’s Imperial College estimates that 2.2 million Americans will die from COVID-19 and that hospital bed demand will be 30 times greater than supply, if no public health measures are taken. The college’s modeling shows that mortality could be reduced by as much as 90 percent based on the intensity and speed with which five non-pharmaceutical measures are implemented. Even with more hopeful assumptions for infectivity and mortality, the anticipated number of deaths for unchecked COVID-19 is striking. Assuming a best-case scenario similar to a typical influenza outbreak, if 20 percent of the roughly 330 million disease-naive people in the United States became infected, and 0.1 percent died, this would still result in 66,000 deaths from unchecked COVID-19. This would create an overwhelming burden for our hospitals.

Historical context

These numbers contrast with the historical mortality from economic downturns. Studies of the U.S. Great Depression (1929-1933), Great Recession (2007-2009), and other periods of worsening economic conditions, demonstrate that mortality actually decreases during periods of economic downturn. In a 2009 publication, Berzruchka writes that, “economic recessions have paradoxical effects on the mortality trends of populations in rich countries. Contrary to what might have been expected, economic downturns during the 20th century were associated with declines in [all-cause] mortality rates.” Ruhm has shown a procyclical relationship between the economy and mortality – meaning that overall mortality increases during economic expansion and decreases during decline.  Statistically, a one-percent increase in unemployment decreases the predicted death rate by 0.5 percent. A 2009 descriptive analyses of associations in health indicators and economic activity for the period of 1920-1940 found that population health evolves better during recessions than expansions.

Mortality from suicide is a notable exception, as it is countercyclical, and increases during economic downturn. However, this increased mortality from suicide does not outweigh the net decrease in overall societal mortality. These mortality findings only apply to higher-income countries. Countries with an annual GDP of less than approximately $5,000 to $10,000 per capita (in 2009 dollars) would expect to see mortality improvements with economic growth.

Several factors may explain these counterintuitive trends. There are fewer traffic and industrial accidents when there is less economic activity, as people are not commuting or performing work. People also have less work-related stress, during times of economic downturn, which might exacerbate health conditions. In addition, without disposable income, people are less likely to engage in behaviors associated with poor health conditions, including drinking and smoking. Consequently, decreases in obesity and cardiovascular disease are often seen during an economic recession. Moreover, people are often home spending time with families and friends and are more physically active during an economic downturn compared to a period of economic expansion.

The disease is more deadly

Public health decisions in the face of the uncertain impact of a new threat are complicated, but when lives are at stake, public health leaders usually recommend the most conservative course to prevent deaths. Our current limited understanding of the transmission, infectivity, presentation, and fatality of COVID-19 has made choosing the best interventions to reduce mortality even more difficult. But watching the horrors of the impact of the thousands of patients overwhelming the hospitals and healthcare workers in Italy, Spain, and New York, is ample evidence that this pandemic requires drastic interventions.

It is clear from historical precedent that the “cure” of public health strategies to suppress COVID-19 will result in significantly less mortality than any potential mortality caused by a resultant economic downturn.

Craig Goolsby and Thomas Kirsch are emergency physicians. Raphaelle H. Rodzik and Nicole Dacuyan-Faucher are epidemiologists. Keke Schuler is a psychologist.

Image credit: Shutterstock.com

Prev

The gift COVID gave me

April 5, 2020 Kevin 0
…
Next

Undergoing an appendectomy in a pandemic

April 5, 2020 Kevin 0
…

Tagged as: COVID, Infectious Disease, Public Health & Policy

Post navigation

< Previous Post
The gift COVID gave me
Next Post >
Undergoing an appendectomy in a pandemic

ADVERTISEMENT

Related Posts

  • How to get patients vaccinated against COVID-19 [PODCAST]

    The Podcast by KevinMD
  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • State sanctioned executions in the age of COVID-19

    Kasey Johnson, DO
  • A patient’s COVID-19 reflections

    Michele Luckenbaugh
  • Starting medical school in the midst of COVID-19

    Horacio Romero Castillo
  • COVID-19 shows why we need health insurance

    Jingyi Liu, MD

More in Conditions

  • Re-examining the lipid hypothesis and statin use

    Larry Kaskel, MD
  • How the internship shortage harms Black students

    Jonathan Lassiter, PhD
  • Aligning psychiatric care and hospital costs

    Lionel Pereira, MD
  • How pediatricians can address infant mortality in underserved communities

    Dr. Tanya Tandon
  • Why our health system fails chronic disease patients

    Kinan Muhammed, MD
  • AI moderation of online health communities

    Kathleen Muldoon, PhD
  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
    • How to stay safe from back-to-school illnesses

      Kevin King, PhD | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast
    • My experiences as an Air Force pediatrician

      Ronald L. Lindsay, MD | Physician
    • Re-examining the lipid hypothesis and statin use

      Larry Kaskel, MD | Conditions
    • How the internship shortage harms Black students

      Jonathan Lassiter, PhD | Conditions
    • How diverse nations tackle health care equity

      Olumuyiwa Bamgbade, MD | Physician
    • What is practical wisdom in medicine?

      Sami Sinada, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
    • How to stay safe from back-to-school illnesses

      Kevin King, PhD | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast
    • My experiences as an Air Force pediatrician

      Ronald L. Lindsay, MD | Physician
    • Re-examining the lipid hypothesis and statin use

      Larry Kaskel, MD | Conditions
    • How the internship shortage harms Black students

      Jonathan Lassiter, PhD | Conditions
    • How diverse nations tackle health care equity

      Olumuyiwa Bamgbade, MD | Physician
    • What is practical wisdom in medicine?

      Sami Sinada, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

COVID-19: Will the disease or the cure cause more death?
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...